Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma Article Swipe
Kazuhiko Sugiyama
,
Yoshitaka Narita
,
Motoo Nagane
,
Kazuhiko Mishima
,
Yasuhito Terui
,
Yoshiki Arakawa
,
Katsunori Asai
,
Noriko Fukuhara
,
Hajime Yonezawa
,
Naoki Shinojima
,
Arata Aoi
,
Ryo Nishikawa
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1080/14796694.2025.2574838
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1080/14796694.2025.2574838
What is this summary about?
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1080/14796694.2025.2574838
- OA Status
- green
- OpenAlex ID
- https://openalex.org/W4415734177
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415734177Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1080/14796694.2025.2574838Digital Object Identifier
- Title
-
Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-31Full publication date if available
- Authors
-
Kazuhiko Sugiyama, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Hajime Yonezawa, Naoki Shinojima, Arata Aoi, Ryo NishikawaList of authors in order
- Landing page
-
https://doi.org/10.1080/14796694.2025.2574838Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/12622348Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4415734177 |
|---|---|
| doi | https://doi.org/10.1080/14796694.2025.2574838 |
| ids.doi | https://doi.org/10.1080/14796694.2025.2574838 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41170813 |
| ids.openalex | https://openalex.org/W4415734177 |
| fwci | 0.0 |
| type | article |
| title | Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma |
| biblio.issue | 27 |
| biblio.volume | 21 |
| biblio.last_page | 3489 |
| biblio.first_page | 3477 |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1080/14796694.2025.2574838 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S174572715 |
| locations[0].source.issn | 1479-6694, 1744-8301 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1479-6694 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Future Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310321119 |
| locations[0].source.host_organization_name | Future Medicine |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310321119 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Future Oncology |
| locations[0].landing_page_url | https://doi.org/10.1080/14796694.2025.2574838 |
| locations[1].id | pmid:41170813 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Future oncology (London, England) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41170813 |
| locations[2].id | pmh:oai:europepmc.org:11430445 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12622348 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5070746851 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Kazuhiko Sugiyama |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210125056 |
| authorships[0].affiliations[0].raw_affiliation_string | aDepartment of Clinical Oncology & Neuro-oncology Program, Hiroshima University Hospital |
| authorships[0].institutions[0].id | https://openalex.org/I4210125056 |
| authorships[0].institutions[0].ror | https://ror.org/038dg9e86 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210125056 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Hiroshima University Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kazuhiko Sugiyama |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | aDepartment of Clinical Oncology & Neuro-oncology Program, Hiroshima University Hospital |
| authorships[1].author.id | https://openalex.org/A5086562781 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4303-6006 |
| authorships[1].author.display_name | Yoshitaka Narita |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210089431 |
| authorships[1].affiliations[0].raw_affiliation_string | bDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital |
| authorships[1].institutions[0].id | https://openalex.org/I4210089431 |
| authorships[1].institutions[0].ror | https://ror.org/0065zqt33 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210089431 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | National Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yoshitaka Narita |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | bDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital |
| authorships[2].author.id | https://openalex.org/A5074447222 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0018-1652 |
| authorships[2].author.display_name | Motoo Nagane |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I190930483 |
| authorships[2].affiliations[0].raw_affiliation_string | cDepartment of Neurosurgery, Kyorin University Faculty of Medicine |
| authorships[2].institutions[0].id | https://openalex.org/I190930483 |
| authorships[2].institutions[0].ror | https://ror.org/0188yz413 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I190930483 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Kyorin University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Motoo Nagane |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | cDepartment of Neurosurgery, Kyorin University Faculty of Medicine |
| authorships[3].author.id | https://openalex.org/A5067016312 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kazuhiko Mishima |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[3].affiliations[0].raw_affiliation_string | dDepartment of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center |
| authorships[3].institutions[0].id | https://openalex.org/I8588240 |
| authorships[3].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Saitama Medical University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kazuhiko Mishima |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | dDepartment of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center |
| authorships[4].author.id | https://openalex.org/A5109523430 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Yasuhito Terui |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210137039, https://openalex.org/I42570316 |
| authorships[4].affiliations[0].raw_affiliation_string | eDepartment of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research |
| authorships[4].institutions[0].id | https://openalex.org/I42570316 |
| authorships[4].institutions[0].ror | https://ror.org/00bv64a69 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I42570316 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Japanese Foundation For Cancer Research |
| authorships[4].institutions[1].id | https://openalex.org/I4210137039 |
| authorships[4].institutions[1].ror | https://ror.org/03md8p445 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210137039 |
| authorships[4].institutions[1].country_code | JP |
| authorships[4].institutions[1].display_name | The Cancer Institute Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yasuhito Terui |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | eDepartment of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research |
| authorships[5].author.id | https://openalex.org/A5057211161 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4626-4645 |
| authorships[5].author.display_name | Yoshiki Arakawa |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I22299242 |
| authorships[5].affiliations[0].raw_affiliation_string | fDepartment of Neurosurgery, Kyoto University Graduate School of Medicine |
| authorships[5].institutions[0].id | https://openalex.org/I22299242 |
| authorships[5].institutions[0].ror | https://ror.org/02kpeqv85 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I22299242 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Kyoto University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Yoshiki Arakawa |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | fDepartment of Neurosurgery, Kyoto University Graduate School of Medicine |
| authorships[6].author.id | https://openalex.org/A5091870544 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-2616-1211 |
| authorships[6].author.display_name | Katsunori Asai |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210151107 |
| authorships[6].affiliations[0].raw_affiliation_string | gDepartment of Neurosurgery, Osaka International Cancer Institute |
| authorships[6].institutions[0].id | https://openalex.org/I4210151107 |
| authorships[6].institutions[0].ror | https://ror.org/05xvwhv53 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210151107 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Osaka International Cancer Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Katsunori Asai |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | gDepartment of Neurosurgery, Osaka International Cancer Institute |
| authorships[7].author.id | https://openalex.org/A5055192416 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2682-2179 |
| authorships[7].author.display_name | Noriko Fukuhara |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210093896 |
| authorships[7].affiliations[0].raw_affiliation_string | hDepartment of Hematology, Tohoku University Hospital |
| authorships[7].institutions[0].id | https://openalex.org/I4210093896 |
| authorships[7].institutions[0].ror | https://ror.org/00kcd6x60 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210093896 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Tohoku University Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Noriko Fukuhara |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | hDepartment of Hematology, Tohoku University Hospital |
| authorships[8].author.id | https://openalex.org/A5080742748 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3144-992X |
| authorships[8].author.display_name | Hajime Yonezawa |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210119230 |
| authorships[8].affiliations[0].raw_affiliation_string | iDepartment of Neurosurgery, Kagoshima University Hospital |
| authorships[8].institutions[0].id | https://openalex.org/I4210119230 |
| authorships[8].institutions[0].ror | https://ror.org/02dkdym27 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210119230 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Kagoshima University Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Hajime Yonezawa |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | iDepartment of Neurosurgery, Kagoshima University Hospital |
| authorships[9].author.id | https://openalex.org/A5024312933 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3352-7936 |
| authorships[9].author.display_name | Naoki Shinojima |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210122547 |
| authorships[9].affiliations[0].raw_affiliation_string | jDepartment of Neurosurgery, Kumamoto University Hospital |
| authorships[9].institutions[0].id | https://openalex.org/I4210122547 |
| authorships[9].institutions[0].ror | https://ror.org/02vgs9327 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210122547 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Kumamoto University Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Naoki Shinojima |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | jDepartment of Neurosurgery, Kumamoto University Hospital |
| authorships[10].author.id | https://openalex.org/A5056523228 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Arata Aoi |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210112155 |
| authorships[10].affiliations[0].raw_affiliation_string | kDepartment of Clinical Development, Ono Pharmaceutical Co., Ltd |
| authorships[10].institutions[0].id | https://openalex.org/I4210112155 |
| authorships[10].institutions[0].ror | https://ror.org/022jefx64 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210112155 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Ono Pharmaceutical (Japan) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Arata Aoi |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | kDepartment of Clinical Development, Ono Pharmaceutical Co., Ltd |
| authorships[11].author.id | https://openalex.org/A5012219489 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5617-8068 |
| authorships[11].author.display_name | Ryo Nishikawa |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[11].affiliations[0].raw_affiliation_string | dDepartment of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center |
| authorships[11].institutions[0].id | https://openalex.org/I8588240 |
| authorships[11].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Saitama Medical University |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Ryo Nishikawa |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | dDepartment of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12622348 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-31T00:00:00 |
| display_name | Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-14T23:14:49.485078 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:europepmc.org:11430445 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400806 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Europe PMC (PubMed Central) |
| best_oa_location.source.host_organization | https://openalex.org/I1303153112 |
| best_oa_location.source.host_organization_name | European Bioinformatics Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1303153112 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12622348 |
| primary_location.id | doi:10.1080/14796694.2025.2574838 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S174572715 |
| primary_location.source.issn | 1479-6694, 1744-8301 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1479-6694 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Future Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310321119 |
| primary_location.source.host_organization_name | Future Medicine |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310321119 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Future Oncology |
| primary_location.landing_page_url | https://doi.org/10.1080/14796694.2025.2574838 |
| publication_date | 2025-10-31 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.is | 1 |
| abstract_inverted_index.What | 0 |
| abstract_inverted_index.this | 2 |
| abstract_inverted_index.about? | 4 |
| abstract_inverted_index.summary | 3 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 12 |
| citation_normalized_percentile |